{
  "success": true,
  "applicability": {
    "isApplicable": false,
    "reasons": [
      {
        "type": "condition",
        "description": "Patient does not have required condition: Premature coronary artery disease",
        "details": "The study required patients to have Premature coronary artery disease"
      },
      {
        "type": "biomarker",
        "description": "Missing biomarker data: HDL-C",
        "details": "The study results are based on HDL-C levels, which are not in the patient's records"
      },
      {
        "type": "biomarker",
        "description": "Missing biomarker data: total cholesterol",
        "details": "The study results are based on total cholesterol levels, which are not in the patient's records"
      },
      {
        "type": "biomarker",
        "description": "Missing biomarker data: lipoprotein(a)",
        "details": "The study results are based on lipoprotein(a) levels, which are not in the patient's records"
      }
    ]
  },
  "patientSummary": {
    "age": 52,
    "sex": "male",
    "relevantBiomarkers": [],
    "relevantConditions": [
      "Type 2 Diabetes Mellitus",
      "Essential Hypertension",
      "Hyperlipidemia"
    ],
    "relevantMedications": [
      "Metformin 1000mg",
      "Lisinopril 10mg",
      "Atorvastatin 20mg"
    ]
  },
  "paperSummary": {
    "title": "Premature coronary artery disease in women: sex-specific risk factors, pathogenetic mechanisms and clinical implications",
    "intervention": "Aggressive lipid control, metabolic risk reduction, and psychosocial support",
    "primaryEndpoint": "Early detection and tailored treatment of female PCAD",
    "population": "Women with premature coronary artery disease (PCAD), defined as onset â‰¤65 years"
  }
}